Lithium Treatment of APPSwDI/NOS2−/− Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype

Open Access

Peer-reviewed

Research Article

Tiffany L. Sudduth,

Affiliation University of Kentucky Sanders-Brown Center on Aging, Department of Physiology, Lexington, Kentucky, United States of America
⨯
Joan G. Wilson,

Affiliation Duke University Medical Center, Department of Medicine, Division of Neurology, Durham, North Carolina, United States of America
⨯
Angela Everhart,

Affiliation Duke University Medical Center, Department of Medicine, Division of Neurology, Durham, North Carolina, United States of America
⨯
Carol A. Colton,

Affiliation Duke University Medical Center, Department of Medicine, Division of Neurology, Durham, North Carolina, United States of America
⨯
Donna M. Wilcock

* E-mail: donna.wilcock@uky.edu

Affiliation University of Kentucky Sanders-Brown Center on Aging, Department of Physiology, Lexington, Kentucky, United States of America
⨯

Reader Comments (0)

Lithium
Is the Subject Area "Lithium" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Diet
Is the Subject Area "Diet" applicable to this article?

Thanks for your feedback.
Genetically modified animals
Is the Subject Area "Genetically modified animals" applicable to this article?

Thanks for your feedback.
Hippocampus
Is the Subject Area "Hippocampus" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Alzheimer's disease
Is the Subject Area "Alzheimer's disease" applicable to this article?

Thanks for your feedback.